This risk assessment evaluates the risk of yellow fever infection, which has seen outbreaks in Angola, Democratic Republic of Congo and Uganda, being introduced into Europe, and sets out a range of options for response.
This report summarises the results of a joint ECDC–European Commission mission team sent to review the epidemiological situation of yellow fever in Angola, following an outbreak in 2015-16.
ECDC has published a rapid risk assessment due to a localised outbreak of neurological symptoms associated with enterovirus A71 (EV-A71) in Catalonia, Spain.
Most EV infections, including EV-A71, result in asymptomatic infection. Most symptomatic EV-A71 infections manifest as a self-limiting hand, foot and mouth disease and only a very small proportion of patients develop severe and life-threatening disease. The current outbreak is notable in terms of its magnitude and the severity of symptoms of the reported cases.
Illnesses caused by infectious diseases are common in children in schools or other childcare settings. Currently there is no common EU approach to the control of communicable diseases in schools or other childcare settings, and existing information is uncertain.
This document assesses the risk of yellow fever infections in Europe related to the ongoing outbreak of yellow fever in Angola, and the notification of imported cases in China and possibly Mauritania.
This risk assessment summarises the development of the 2015–16 influenza season, which so far has been characterised by a prevalence of type A viruses.
This risk assessment focuses on the threat to the refugee population from communicable diseases and assesses the situation in Europe, associated with the current movements of refugees across the region and in the context of their living conditions and the approaching winter, access to shelter, sanitation and health services.